NASDAQ: PXMDPaxmedica Inc Stock Ownership - Who owns Paxmedica?
Insider buying vs selling
Have Paxmedica Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Zachary Rome | Chief Operating Officer | 2023-03-09 | 3,371 | $1.44 | $4.85kSell |
| Karen Larochelle | Director | 2023-03-09 | 335 | $1.48 | $495.80Sell |
| Howard J. Weisman | Chief Executive Officer | 2023-03-09 | 3,495 | $1.44 | $5.03kSell |
| Michael Derby | Executive Chairman | 2023-03-09 | 2,143 | $1.43 | $3.06kSell |
| John F. Coelho | Director | 2023-03-09 | 130 | $1.48 | $192.40Sell |
| Howard J. Weisman | Chief Executive Officer | 2023-03-08 | 32,397 | $1.46 | $47.30kSell |
| Zachary Rome | Chief Operating Officer | 2023-03-08 | 30,034 | $1.47 | $44.15kSell |
| Michael Derby | Executive Chairman | 2023-03-07 | 15,134 | $1.55 | $23.46kSell |
| Zachary Rome | Chief Operating Officer | 2023-03-07 | 23,432 | $1.53 | $35.85kSell |
| Howard J. Weisman | Chief Executive Officer | 2023-03-07 | 23,551 | $1.53 | $36.03kSell |
PXMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when PXMD insiders and whales buy or sell their stock.
PXMD Shareholders
What type of owners hold Paxmedica Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Michael Derby | 65.04% | 7,661,175 | $16.32M | Insider |
| Tardimed Sciences LLC | 62.28% | 7,336,745 | $15.63M | Insider |
| Howard J. Weisman | 4.60% | 541,633 | $1.15M | Insider |
| Zachary Rome | 2.45% | 288,452 | $614.40k | Insider |
| Stephen Sheldon | 1.43% | 168,799 | $359.54k | Insider |
| John F. Coelho | 0.57% | 67,235 | $143.21k | Insider |
| Charles J. Casamento | 0.44% | 51,583 | $109.87k | Insider |
| Karen Larochelle | 0.36% | 42,415 | $90.34k | Insider |
| Ubs Group Ag | 0.28% | 33,404 | $71.15k | Institution |
| State Street Corp | 0.19% | 21,900 | $46.65k | Institution |
PXMD vs Biotech Stocks
Paxmedica Stock Ownership FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.